Table 1.
Aglycone | Aglycone's effect | Disease/health | Refs. |
---|---|---|---|
Endogenous | |||
Arachidonic acid | Signaling molecule | Inflammation | 48 |
Bilirubin | Neurotoxin, antioxidant | Gall stones, jaundice | 19 |
Chenodeoxycholate | Digestion | Cholestasis | 89 |
Chondroitin sulfate | Glycosaminoglycan | Cancer | 90 |
Dopamine | GI motility, water absorption | IBD, constipation | 5 |
Estradiol | Sex hormone, development | Breast cancer | 26 |
Hyaluronic acid | Glycosaminoglycan | Cancer | 10 |
Norepinephrine | GI motility | IBD | 5 |
Serotonin | GI motility | IBD | 40 |
Testosterone | Sex hormone | Prostate cancer | 32 |
Thyroxine | Thyroid regulation | Metabolic disorder | 36 |
Exogenous | |||
AOM | Alkylating agent | Cancer | 66 |
Belinostat | HDAC inhibitor | GI toxicity | 57 |
Benzo[a]pyrene | DNA adduct formation | Cancer | 70 |
Diclofenac | NSAID | GI toxicity | 62 |
Ethanol | Depressant | Liver toxicity | 91 |
Indomethacin | NSAID | GI toxicity | 64 |
Ketoprofen | NSAID | GI toxicity | 62 |
Nicotine | Stimulant | Addiction | 75 |
Panobinostat | HDAC inhibitor | GI toxicity | 58 |
PhIP | Alkylating agent | Cancer | 69 |
SN-38 | Topoisomerase I inhibitor | GI toxicity | 54 |